HAEMONETICS CORP — Director's Dealing 2013

Feb 28, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2013-02-26

Reporting Person: White Jonathan (VP Research and Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-26	Common Stock	S	3000.0	$40.69	Disposed	0	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	24727	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Stock Option (right to buy)	$26.47	2016-10-27	Common Stock (24484)	24484	Direct
Non-Qualified Stock Option (right to buy)	$27.495	2017-10-27	Common Stock (30776)	30776	Direct
Non-Qualified Stock Option (right to buy)	$30.025	2016-01-28	Common Stock (35282)	35282	Direct
Non-Qualified Stock Option (right to buy)	$30.67	2018-10-25	Common Stock (35130)	35130	Direct
Non-Qualified Stock Option (right to buy)	$33.925	2018-07-20	Common Stock (27948)	27948	Direct
Non-Qualified Stock Option (right to buy)	$39.055	2019-10-24	Common Stock (32192)	32192	Direct

Footnotes

F1: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.